David has over 20 years’ experience in the bio-pharmaceutical and R&D industry. He has expertise in advancing neuroscience-based programs to the clinic for a range of CNS disorders. In addition, his in-depth expertise in drug development has led to the progression of multiple assets through clinical trials, as well as playing a key role in the negotiation of major partnerships. Prior to joining Evox Therapeutics, David was Head of Pharmacology at AbbVie in Germany, and also worked at GlaxoSmithKline (GSK) for 10 years. David is a Pharmacologist and Neuroscientist by training, obtaining his Ph.D. from the Institute of Psychiatry at King’s College London.